Factor V Leiden Mutation in a Case with Ischemic Stroke: Which Relationship?
Angiology 49:79-82, Orlandi, G.,et al, 1998
A Pharmacoeconomic Eval of IV Fosphenytoin (Cerebyx) vs IV Phenytoin (Dilantin) in Hosp ER Dept
Clin Therapeutics 18:953-966, Marchetti,A.,et al, 1996
Complications of Intravenous Immune Globulin Treatment in Neurologic Disease
Neurol 47:674-677, Brannagan III,T.H.,et al, 1996
Cerebral Venous Thrombosis:Role of Activated Protein C Resistance and Factor V Gene Mutation
Stroke 27:1719-1720, Brey,R.L.&Coull,B.M., 1996
Medical Complications During Stroke Rehabilitation
Stroke 26:990-994, Kalra,L.,et al, 1995
Ischemic Stroke in Young Pts with Activated Protein C Resistance:Rpt of Three Cases Belonging to Three Different Kindreds
Stroke 26:885-890, Simioni,P.,et al, 1995
Transesophageal Echocardiography & Contrast-TCD in the Detection of a Patent Foramen Ovale:Experiences with 111 Pts
Neurol 44:1603-1606, Klotzsch,C.,et al, 1994
Intensive Care of Acute Guillain-Barre Syndrome
Can J Neurol Sci 21:S23-S27, Ropper.,A.H., 1994
The Prevalence of Deep Venous Thrombosis in Patients with Suspected Paradoxical Embolism
Ann Int Med 119:461-465, Stollberger,C.,et al, 1993
Complications of Therapy for Venous Thromboembolic Disease in Patients with Brain Tumors
Neurol 43:1111-1114, Levin,J.M.,et al, 1993
Venous Thromboembolism in Acute Stroke, Prognostic Importance of Hypercoagulability
Arch Neurol 49:279-283, Landi,G.,et al, 1992
Complications of Acute Stroke
Lancet 339:721-724, Oppenheimer,S.&Hachinski,V., 1992
Venous Thromboembolism in Stroke:Literature Review and Implications for Clinical Practice
Arch Phys Med Rehabil 73:379-391, Brandstater,M.E.,et al, 1992
Early Heparin Therapy in Patients with Spontaneous Intracerebral Haemorrhage
JNNP 54:466-467, Boeer,A.,et al, 1991
Atrial Fibrillation as a Risk Factor for Deep Venous Thrombosis and Pulmonary Emboli in Stroke Patients
Stroke 22:760-762, Noel,P.,et al, 1991
Acute Cerebrovascular Episodes in Systemic Lupus Erythematosus
Quart J Med 293:739-750, Eustace,S.,et al, 1991
The Evolution of Oral Contraceptives Maximizing Efficacy, Minimizing Risks
Acta Obstet Gynecol Scand (Suppl) 152:7-12990., Hedon,B., 1990
Prevalence of Patent Foramen Ovale in Patients with Stroke
NEJM 318:1148-1152, 11971988., Lechat,P.,et al, 1988
Levodopa Methyl Ester Treatment of Parkinson's Disease
Neurol 37:1242-1245, Juncos,J.L.,et al, 1987
Ischemic Stroke Associated with Anticardiolipin Antibodies
Stroke 18:1101-1106, Levine,S.R.,et al, 1987
Cerebral Haemorrhagic Infarction in Young Patients with Hereditary Protein C Deficiency
BMJ 290:350-352, Wintzen,A.R.,et al, 1985
Incidence & Treatment of Peripheral Venous Thrombosis in Patients with Glioma
Ann Neurol 13:334-336, Ruff,R.L.,et al, 1983
Cerebral Emboli of Paradoxical Origin
Ann Neurol 13:314-319, Jones,H.R.,et al, 1983
Nonbacterial Thrombotic Endocarditis
Arch Neurol 39:95-98, Biller,J.,et al, 1982
Behcet's Syndrome
NEJM 301:431-432, James,D.G., 1979
Sagittal Sinus Thrombosis as a Complication of Regional Enteritis
Ann Neruol 3:450, Sigsbee,B.,et al, 1978
Superior Sagittal Sinus Thrombosis
Arch Neurol 34:2, Gettelfinger,D.M.,et al, 1977
Neuro-Behcet Disease:Two Cases & Neuroradiologic Findings
Neurol 27:1148, Kozin,F.,et al, 1977
Chronic Meningitis
Medicine 55:341, Ellner,J.J.,et al, 1976
Cerebral Embolism Caused by Nonbacterial Thrombotic Endocarditis
Neurol 10:391, Barron,K.D.,et al, 1960
Intravenous Thrombolysis Use in the Late Time Window Before Interhospital Transfer for Thrombectomy
JAMA Neurol 83:60-67, Seners,P.,et al, 2026
Tenecteplase for Acute Non-Large Vessel Occlusion 4.5 to 24 Hours After IschemicStroke, The OPTION Randomized Clinical Trial
JAMA doi:10.1001/JAMA.2026.0210, Ma,G.,et al, 2026
A Randomized Trial of Tenecteplase in Acute Central Retinal Artery Occlusion
NEJM 394:442-450, Ryan,S.J.,et al, 2026
Deep Venous Dural Arteriovenous Fistula Mimicking Progressive Dementia
Stroke 57:e180-181, Langlois-Therien,T.,et al, 2026
Endovascular Venous Sinus Stenting versus CSF Shunting for Idiopathic Intracranial Hypertssion:Nationwide Real-World Outcomes
AJNR 47:1238-1243, Chen,H.,et al, 2026
Endovascular Therapy for Medium-Vessel Occlusion Stroke - Narrowing the Target Population
NEJM 394:1955-1957,1894, Ospel,J.M. & Hill, M.D., 2026
Safety and Outcomes of Dibigatran Reversal with Idarucizumab Before IV Thrombolysis in Patients with Acute Ischemic Stroke
Neurol 106:e218012, Saflund,M.,et al, 2026
Cerebral Syphilitic Vasculitis Presenting with Recurrent Stroke
Stroke 57:e197-e198, Yilmaz,E.,et al, 2026
Cavernous Sinus Thrombosis
Stat Pearls June 16, Plewa,M.C. & Hall, W.A., 2025
Intravenous Thrombolysis Use Before Inter-Facility Transfer for Thrombectomy:Association with Efficacy and Safety Outcomes
Ann Neurol 98:871-880, Seners,P.,et al, 2025
Effectiveness and Safety of IV Thrombolysis Before Hospital Transfer for Thrombectomy in Patients With Basilar Artery Occlusion
Neurol 105:e214355, Liebart,S.,et al, 2025
Upbeat Nystagmus From Dorsolateral Pontine Hemorrhagic Transformation
Neurol 106:e214467, Chen,H. & Li, J., 2025
When the "Eye Falls", Diagnosing Orbital Varix
Neurol 106:e214568, Shor,N.,et al, 2025
Endovascular Treatment in Acute Ischemic Stroke Due to Occlusion of Medium or Distal Vessels
Neurol 105:e214015, Palaiodimou,L.,et al, 2025
The Multifactorial Nature of Ischemic Stroke in Malignancy
Stroke 56:e303-e306, Doyle,C.L.,et al, 2025
Early Tirofiban Infusion after Intravenous Thrombolysis for Stroke
NEJM 393:1191-1201, Tao,C.,et al, 2025
Idiopathic Intracranial Hypertension
NEJM 393:1409-1414, Horton,J.C., 2025
Endovascular Thrombectomy Versus Best Medical Therapy for Large Vessel Occlusion Stroke Beyond 24 Hours: A Systematic Review and Meta-Analysis
Stroke 56:3127-3137, Rodriguez-Caliemnes,A.,et al, 2025
Early Thrombolysis and Outcomes in Central Retinal Artery Occlusion:An Individual Participant Data Meta-Analysis
Stroke 56:3175-3186, Xie,J.S.,et al, 2025
Effectiveness of Endovascular Treatment for Acute Mild Basilar Artery Occlusion Stroke:A Multicenter Real-World Study
Stroke 56:3187-3198, Xiao,Y.,et al, 2025